Since cerebral insulin resistance is an early pathological event during AD and PD, while GLP-1 mimetics were shown to re-sensitize insulin-signaling in the brain (section “Insulin resistance and the neuronal energy metabolism”), this represents another mechanism that preserves the mitochondrial function during neurodegenerative diseases. This evidence concerns the gene INS and Parkinson disease.